Platelet Protein May Explain Blood Clot Risk for People with Type 2 Diabetes

Platelet protein may explain blood clot risk for people with type 2 diabetes

New research from the Charles Perkins Center at the University of Sydney has uncovered a new biological pathway that may help explain why people with type 2 diabetes are more prone to developing dangerous blood clots, potentially paving the way for future treatments that reduce their cardiovascular risk.

Breakthrough treatment reduces heart attack and stroke risk for type 2 diabetics

A team of scientists from the University of Sydney’s Charles Perkins Centre has discovered a previously unknown biological pathway that could explain why people with type 2 diabetes face a higher risk of dangerous blood clots. The work, published in the Journal of Clinical Investigation, offers new hope for treatments that may one day lower the odds of heart attack and stroke in this group. Led by Associate Professor Freda Passam from the Centra…

New discovery could lower heart attack and stroke risk for people with